<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Acta Naturae</journal-id><journal-title-group><journal-title xml:lang="en">Acta Naturae</journal-title><trans-title-group xml:lang="ru"><trans-title>Acta Naturae</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-8251</issn><publisher><publisher-name xml:lang="en">Acta Naturae Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">27590</article-id><article-id pub-id-type="doi">10.32607/actanaturae.27590</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Research Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Экспериментальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Recombinant production, species-specific activity at the TRPA1 channel, and significance of the N-terminal residue of ProTx-I toxin from <italic>Thrixopelma pruriens</italic> tarantula venom</article-title><trans-title-group xml:lang="ru"><trans-title>Рекомбинантная продукция, видоспецифическая активность на канале TRPA1 и важная роль N-концевого остатка токсина ProTx-I из яда тарантула <italic>Thrixopelma pruriens</italic></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shulepko</surname><given-names>Mikhail A.</given-names></name><name xml:lang="ru"><surname>Шулепко</surname><given-names>Михаил Анатольевич</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>Faculty of Biology</p></bio><bio xml:lang="ru"><p>Биологический факультет</p></bio><email>mikhailshulepko@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhang</surname><given-names>Mendi</given-names></name><name xml:lang="ru"><surname>Джан</surname><given-names>Менди</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>Faculty of Biology</p></bio><bio xml:lang="ru"><p>Биологический факультет</p></bio><email>zmd010816@163.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhivov</surname><given-names>Eugenii A.</given-names></name><name xml:lang="ru"><surname>Живов</surname><given-names>Евгений Андреевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>evgeniy-kovalenko2016@mail.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kulbatskii</surname><given-names>Dmitrii S.</given-names></name><name xml:lang="ru"><surname>Кульбацкий</surname><given-names>Дмитрий Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>d.kulbatskiy@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3614-560X</contrib-id><name-alternatives><name xml:lang="en"><surname>Paramonov</surname><given-names>Alexander S.</given-names></name><name xml:lang="ru"><surname>Парамонов</surname><given-names>Александр Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>apar@nmr.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Che</surname><given-names>Yuqi</given-names></name><name xml:lang="ru"><surname>Чэ</surname><given-names>Юйци</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>Faculty of Biology</p></bio><bio xml:lang="ru"><p>Биологический факультет</p></bio><email>cheyuqi1997@163.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kuznetsov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Кузнецов</surname><given-names>Александр В.</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>Faculty of Biology</p></bio><bio xml:lang="ru"><p>Биологический факультет</p></bio><email>kuznetsov.a25@icloud.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Popov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Попов</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>lyukmanova_ekaterina@smbu.edu.cn</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kirpichnikov</surname><given-names>Mikhail P.</given-names></name><name xml:lang="ru"><surname>Кирпичников</surname><given-names>Михаил Петрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Interdisciplinary Scientific and Educational School “Molecular Technologies of the Living Systems and Synthetic Biology”, Faculty of Biology, Lomonosov Moscow State University</p></bio><bio xml:lang="ru"><p>Междисциплинарная научно-образовательная школа «Молекулярные технологии живых систем и синтетическая биология», биологический факультет Московского государственного университета им. М.В. Ломоносова</p></bio><email>kirpichnikov@inbox.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff5"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shenkarev</surname><given-names>Zakhar O.</given-names></name><name xml:lang="ru"><surname>Шенкарев</surname><given-names>Захар Олегович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>zakhar-shenkarev@yandex.ru</email><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lyukmanova</surname><given-names>Ekaterina N.</given-names></name><name xml:lang="ru"><surname>Люкманова</surname><given-names>Екатерина Назымовна</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>Faculty of Biology, Shenzhen MSU-BIT University; Interdisciplinary Scientific and Educational School “Molecular Technologies of the Living Systems and Synthetic Biology”, Faculty of Biology, Lomonosov Moscow State University</p></bio><bio xml:lang="ru"><p>Биологический факультет, Шэньчжэньский МГУ-ППИ Университет; Междисциплинарная научно-образовательная школа «Молекулярные технологии живых систем и синтетическая биология», биологический факультет Московского государственного университета им. М.В. Ломоносова</p></bio><email>lyukmanova_ekaterina@smbu.edu.cn</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff5"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Shenzhen MSU-BIT University</institution></aff><aff><institution xml:lang="ru">Шэньчжэньский МГУ-ППИ Университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry</institution></aff><aff><institution xml:lang="ru">Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Moscow Center for Advanced Studies</institution></aff><aff><institution xml:lang="ru">Московский центр перспективных исследований</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Kurchatov Medical Primatology Center of National Research Center “Kurchatov Institute”</institution></aff><aff><institution xml:lang="ru">Курчатовский комплекс медицинской приматологии НИЦ «Курчатовский институт»</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-12-04" publication-format="electronic"><day>04</day><month>12</month><year>2025</year></pub-date><volume>17</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>121</fpage><lpage>129</lpage><history><date date-type="received" iso-8601-date="2024-12-11"><day>11</day><month>12</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2025-07-03"><day>03</day><month>07</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Shulepko M.A., Zhang M., Zhivov E.A., Kulbatskii D.S., Paramonov A.S., Che Y., Kuznetsov A.V., Popov A.V., Kirpichnikov M.P., Shenkarev Z.O., Lyukmanova E.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Шулепко М.А., Джан М., Живов Е.А., Кульбацкий Д.С., Парамонов А.С., Чэ Ю., Кузнецов А.В., Попов А.В., Кирпичников М.П., Шенкарев З.О., Люкманова Е.Н.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Shulepko M.A., Zhang M., Zhivov E.A., Kulbatskii D.S., Paramonov A.S., Che Y., Kuznetsov A.V., Popov A.V., Kirpichnikov M.P., Shenkarev Z.O., Lyukmanova E.N.</copyright-holder><copyright-holder xml:lang="ru">Шулепко М.А., Джан М., Живов Е.А., Кульбацкий Д.С., Парамонов А.С., Чэ Ю., Кузнецов А.В., Попов А.В., Кирпичников М.П., Шенкарев З.О., Люкманова Е.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://actanaturae.ru/2075-8251/article/view/27590">https://actanaturae.ru/2075-8251/article/view/27590</self-uri><abstract xml:lang="en"><p>The ProTx-I toxin from <italic>Thrixopelma pruriens</italic> tarantula venom inhibits voltage-gated sodium (Na<sub>V</sub>), potassium, and calcium channels, as well as the chemosensitive TRPA1 ion channel, affecting the activating processes of these channels. Due to its action at the Na<sub>V</sub>1.7, Na<sub>V</sub>1.8, and TRPA1 channels involved in pain perception and propagation, ProTx-I may be used as a model for the development of next-generation analgesics. ProTx-I consists of 35 amino acid residues, with three disulfide bonds forming an inhibitor cystine knot (ICK) motif, which challenges its heterologous production. An efficient ProTx-I production system is necessary to study, at the molecular level, the mechanism by which the toxin acts. In this study, we tested several approaches for bacterial production of disulfide-containing toxins. Cytoplasmic expression of ProTx-I fused with either thioredoxin or glutathione-S-transferase failed to yield a correctly folded toxin. However, the natively folded ProTx-I was successfully obtained by “direct” expression in the form of cytoplasmic inclusion bodies, followed by renaturation, as well as by secretion into the periplasmic space via fusion with maltose-binding protein. The activity of the recombinant ProTx-I was studied by electrophysiology in <italic>X. laevis</italic> oocytes expressing rat and human TRPA1 channels. The toxin proved to be more active on the rat channel than on the human channel (IC<sub>50</sub> = 250 ± 85 and 840 ± 190 nM, respectively). The presence of an additional <italic>N</italic>-terminal methionine residue in the toxin obtained through “direct” expression significantly attenuated its activity.</p></abstract><trans-abstract xml:lang="ru"><p>Токсин ProTx-I из яда тарантула <italic>Thrixopelma pruriens</italic> ингибирует потенциал-зависимые натриевые (Na<sub>V</sub>), калиевые и кальциевые каналы, а также хемочувствительный канал TRPA1, влияя на процессы их активации. Благодаря активности в отношении каналов Na<sub>V</sub>1.7, Na<sub>V</sub>1.8 и TRPA1, участвующих в восприятии и распространении болевых сигналов, ProTx-I может рассматриваться в качестве модели для создания анальгетиков нового поколения. ProTx-I состоит из 35 аминокислотных остатков, при этом три дисульфидные связи в его структуре образуют мотив ингибиторного цистинового узла, что затрудняет рекомбинантную продукцию токсина. Разработка эффективной системы продукции ProTx-I необходима для изучения механизма действия токсина на молекулярном уровне. В представленной работе мы сравнили ряд подходов к бактериальной продукции дисульфидсодержащих токсинов. Цитоплазматическая экспрессия ProTx-I в составе слитого растворимого белка с тиоредоксином или глутатион-S-трансферазой не позволила получить правильно свернутый токсин. В то же время ProTx-I с природной структурой был получен в ходе «прямой» экспрессии в виде цитоплазматических телец включения с последующей ренатурацией, а также при секреции в периплазматическое пространство в слитой конструкции с мальтозосвязывающим белком. Активность рекомбинантного ProTx-I была изучена электрофизиологическими методами на ооцитах <italic>X</italic><italic>enopus laevis</italic>, экспрессирующих каналы TRPA1 крысы и человека. Токсин показал б<italic>о</italic>льшую активность на канале крысы, чем на канале человека (IC<sub>50</sub> = 250 ± 70 и 840 ± 190 нМ соответственно). Также было обнаружено, что наличие дополнительного N-концевого остатка метионина у токсина, полученного в ходе «прямой» экспрессии, значительно ослабляет активность ProTx-I.</p></trans-abstract><kwd-group xml:lang="en"><kwd>cystine knot</kwd><kwd>TRPA1 channel</kwd><kwd>gating modifier toxin</kwd><kwd>bacterial production</kwd><kwd>disulfide-rich proteins</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>цистиновый узел</kwd><kwd>TRPA1</kwd><kwd>токсин, влияющий на активацию</kwd><kwd>бактериальная продукция</kwd><kwd>дисульфид-богатые белки</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Российский научный фонд</institution></institution-wrap><institution-wrap><institution xml:lang="en">Russian Science Foundation</institution></institution-wrap></funding-source><award-id>22-14-00326</award-id></award-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Министерство образования провинции Гуандун Китая</institution></institution-wrap><institution-wrap><institution xml:lang="en">Ministry of Education of Guangdong Province of China</institution></institution-wrap></funding-source><award-id>2022KCXTD034</award-id></award-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Министерство образования провинции Гуандун Китая</institution></institution-wrap><institution-wrap><institution xml:lang="en">Ministry of Education of Guangdong Province of China</institution></institution-wrap></funding-source><award-id>2023ZDZX2072</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Kuhn-Nentwig L, Stöcklin R, Nentwig W. Venom Composition and Strategies in Spiders. Is Everything Possible? Adv Insect Physiol. 2011;40:1−86. doi: 10.1016/B978-0-12-387668-3.00001-5</mixed-citation><mixed-citation xml:lang="ru">Kuhn-Nentwig L, Stöcklin R, Nentwig W. Venom Composition and Strategies in Spiders. In: Advances in Insect Physiology. Vol 40. Elsevier; 2011:1−86. doi: 10.1016/B978-0-12-387668-3.00001-5</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><mixed-citation>Peigneur S, de Lima ME, Tytgat J. Phoneutria nigriventer venom: A pharmacological treasure. Toxicon. 2018;151:96−110. doi: 10.1016/j.toxicon.2018.07.008</mixed-citation></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Lyukmanova EN, Shenkarev ZO. Toxins from Animal Venom − A Rich Source of Active Compounds with High Pharmacological Potential. Toxins (Basel). 2024;16(12):512. doi: 10.3390/toxins16120512</mixed-citation><mixed-citation xml:lang="ru">Lyukmanova EN, Shenkarev ZO. Toxins from Animal Venom—A Rich Source of Active Compounds with High Pharmacological Potential. Toxins. 2024;16(12):512. doi: 10.3390/toxins16120512</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><mixed-citation>Cardoso FC, Lewis RJ. Structure-Function and Therapeutic Potential of Spider Venom-Derived Cysteine Knot Peptides Targeting Sodium Channels. Front Pharmacol. 2019;10:366. doi: 10.3389/fphar.2019.00366</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kintzing JR, Cochran JR. Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles. Curr Opin Chem Biol. 2016;34:143−150. doi: 10.1016/j.cbpa.2016.08.022</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Milescu M, Bosmans F, Lee S, Alabi AA, Kim JI, Swartz KJ. Interactions between lipids and voltage sensor paddles detected with tarantula toxins. Nat Struct Mol Biol. 2009;16(10):1080−1085. doi: 10.1038/nsmb.1679</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Middleton RE, Warren VA, Kraus RL, et al. Two tarantula peptides inhibit activation of multiple sodium channels. Biochemistry. 2002;41(50):14734−14747. doi: 10.1021/bi026546a</mixed-citation></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Gui J, Liu B, Cao G, et al. A Tarantula-Venom Peptide Antagonizes the TRPA1 Nociceptor Ion Channel by Binding to the S1–S4 Gating Domain. Curr Biol. 2014;24(5):473−483. doi: 10.1016/j.cub.2014.01.013</mixed-citation><mixed-citation xml:lang="ru">Gui J, Liu B, Cao G, et al. A Tarantula-Venom Peptide Antagonizes the TRPA1 Nociceptor Ion Channel by Binding to the S1–S4 Gating Domain. Current Biology. 2014;24(5):473−483. doi:10.1016/j.cub.2014.01.013</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Maatuf Y, Geron M, Priel A. The Role of Toxins in the Pursuit for Novel Analgesics. Toxins (Basel). 2019;11(2):131. doi: 10.3390/toxins11020131</mixed-citation><mixed-citation xml:lang="ru">Maatuf Y, Geron M, Priel A. The Role of Toxins in the Pursuit for Novel Analgesics. Toxins (Basel). 2019;11(2). doi:10.3390/toxins11020131</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Souza Monteiro de Araujo D, Nassini R, Geppetti P, De Logu F. TRPA1 as a therapeutic target for nociceptive pain. Expert Opin Ther Targets. 2020;24(10):997−1008. doi: 10.1080/14728222.2020.1815191</mixed-citation><mixed-citation xml:lang="ru">Souza Monteiro de Araujo D, Nassini R, Geppetti P, De Logu F. TRPA1 as a therapeutic target for nociceptive pain. Expert Opinion on Therapeutic Targets. 2020;24(10):997−1008. doi: 10.1080/14728222.2020.1815191</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><mixed-citation>Dormer A, Narayanan M, Schentag J, et al. A Review of the Therapeutic Targeting of SCN9A and Nav1.7 for Pain Relief in Current Human Clinical Trials. J Pain Res. 2023;16:1487−1498. doi: 10.2147/JPR.S388896</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Moore SJ, Cochran JR. Engineering knottins as novel binding agents. Methods Enzymol. 2012;503:223−251. doi: 10.1016/B978-0-12-396962-0.00009-4</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Fitches EC, Pyati P, King GF, Gatehouse JA. Fusion to snowdrop lectin magnifies the oral activity of insecticidal ω-Hexatoxin-Hv1a peptide by enabling its delivery to the central nervous system. PLoS One. 2012;7(6):e39389. doi: 10.1371/journal.pone.0039389</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Yang S, Pyati P, Fitches E, Gatehouse JA. A recombinant fusion protein containing a spider toxin specific for the insect voltage-gated sodium ion channel shows oral toxicity towards insects of different orders. Insect Biochem Mol Biol. 2014;47(100):1−11. doi: 10.1016/j.ibmb.2014.01.007</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Monfared N, Ahadiyat A, Fathipour Y, Mianroodi RA. Evaluation of recombinant toxin JFTX-23, an oral-effective anti-insect peptide from the spider Selenocosmia jiafu venom gland proteome. Toxicon. 2022;217:78−86. doi: 10.1016/j.toxicon.2022.08.003</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Matsubara FH, Meissner GO, Herzig V, et al. Insecticidal activity of a recombinant knottin peptide from Loxosceles intermedia venom and recognition of these peptides as a conserved family in the genus. Insect Mol Biol. 2017;26(1):25−34. doi: 10.1111/imb.12268</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Costa S, Almeida A, Castro A, Domingues L. Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 system. Front Microbiol. 2014;5:63. doi: 10.3389/fmicb.2014.00063</mixed-citation></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Berlec A, Strukelj B. Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells. J Ind Microbiol Biotechnol. 2013;40(3−4):257−274. doi: 10.1007/s10295-013-1235-0</mixed-citation><mixed-citation xml:lang="ru">Berlec A, Strukelj B. Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells. J Ind Microbiol Biotechnol. 2013;40(3-4):257−274. doi: 10.1007/s10295-013-1235-0</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><mixed-citation>Klint JK, Senff S, Saez NJ, et al. Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli. PLoS One. 2013;8(5):e63865. doi: 10.1371/journal.pone.0063865</mixed-citation></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Anangi R, Rash LD, Mobli M, King GF. Functional Expression in Escherichia coli of the Disulfide-Rich Sea Anemone Peptide APETx2, a Potent Blocker of Acid-Sensing Ion Channel 3. Mar Drugs. 2012;10(7):1605−1618. doi: 10.3390/md10071605</mixed-citation><mixed-citation xml:lang="ru">Anangi R, Rash LD, Mobli M, King GF. Functional Expression in Escherichia coli of the Disulfide-Rich Sea Anemone Peptide APETx2, a Potent Blocker of Acid-Sensing Ion Channel 3. Marine Drugs. 2012;10(7):1605−1618. doi: 10.3390/md10071605</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Logashina YA, Solstad RG, Mineev KS, et al. New Disulfide-Stabilized Fold Provides Sea Anemone Peptide to Exhibit Both Antimicrobial and TRPA1 Potentiating Properties. Toxins (Basel). 2017;9(5):154. doi: 10.3390/toxins9050154</mixed-citation><mixed-citation xml:lang="ru">Logashina YA, Solstad RG, Mineev KS, et al. New Disulfide-Stabilized Fold Provides Sea Anemone Peptide to Exhibit Both Antimicrobial and TRPA1 Potentiating Properties. Published online 2017:23.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Lyukmanova EN, Mironov PA, Kulbatskii DS, et al. Recombinant Production, NMR Solution Structure, and Membrane Interaction of the Phα1β Toxin, a TRPA1 Modulator from the Brazilian Armed Spider Phoneutria nigriventer. Toxins (Basel). 2023;15(6):378. doi: 10.3390/toxins15060378</mixed-citation><mixed-citation xml:lang="ru">Lyukmanova EN, Mironov PA, Kulbatskii DS, et al. Recombinant Production, NMR Solution Structure, and Membrane Interaction of the Phα1β Toxin, a TRPA1 Modulator from the Brazilian Armed Spider Phoneutria nigriventer. Toxins. 2023;15(6):378. doi: 10.3390/toxins15060378</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><mixed-citation>Berkut AA, Peigneur S, Myshkin MY, et al. Structure of Membrane-active Toxin from Crab Spider Heriaeus melloteei Suggests Parallel Evolution of Sodium Channel Gating Modifiers in Araneomorphae and Mygalomorphae. J Biol Chem. 2015;290(1):492−504. doi: 10.1074/jbc.M114.595678</mixed-citation></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Shlyapnikov YM, Andreev YA, Kozlov SA, Vassilevski AA, Grishin EV. Bacterial production of latarcin 2a, a potent antimicrobial peptide from spider venom. Protein Expr Purif. 2008;60(1):89−95. doi: 10.1016/j.pep.2008.03.011</mixed-citation><mixed-citation xml:lang="ru">Shlyapnikov YM, Andreev YA, Kozlov SA, Vassilevski AA, Grishin EV. Bacterial production of latarcin 2a, a potent antimicrobial peptide from spider venom. Protein Expression and Purification. 2008;60(1):89−95. doi: 10.1016/j.pep.2008.03.011</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><mixed-citation>Paiva ALB, Matavel A, Peigneur S, et al. Differential effects of the recombinant toxin PnTx4(5-5) from the spider Phoneutria nigriventer on mammalian and insect sodium channels. Biochimie. 2016;121:326−335. doi: 10.1016/j.biochi.2015.12.019</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Zhang H, Huang PF, Meng E, et al. An efficient strategy for heterologous expression and purification of active peptide hainantoxin-IV. PLoS One. 2015;10(2):e0117099. doi: 10.1371/journal.pone.0117099</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Shulepko MA, Lyukmanova EN, Shenkarev ZO, et al. Towards universal approach for bacterial production of three-finger Ly6/uPAR proteins: Case study of cytotoxin I from cobra N. oxiana. Protein Expr Purif. 2017;130:13−20. doi: 10.1016/j.pep.2016.09.021</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Andreev YA, Kozlov SA, Vassilevski AA, Grishin EV. Cyanogen bromide cleavage of proteins in salt and buffer solutions. Anal Biochem. 2010;407(1):144−146. doi: 10.1016/j.ab.2010.07.023</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Rupasinghe DB, Herzig V, Vetter I, et al. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target NaV1.7. Biochem Pharmacol. 2020;181:114080. doi: 10.1016/j.bcp.2020.114080</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Vásquez-Escobar J, Benjumea-Gutiérrez DM, Lopera C, et al. Heterologous Expression of an Insecticidal Peptide Obtained from the Transcriptome of the Colombian Spider Phoneutria depilate. Toxins (Basel). 2023;15(7):436. doi: 10.3390/toxins15070436</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Dubovskii PV, Dubinnyi MA, Konshina AG, et al. Structural and Dynamic “Portraits” of Recombinant and Native Cytotoxin I from Naja oxiana: How Close Are They? Biochemistry. 2017;56(34):4468−4477. doi: 10.1021/acs.biochem.7b00453</mixed-citation></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Lyukmanova EN, Shenkarev ZO, Khabibullina NF, et al. N-terminal fusion tags for effective production of g-protein-coupled receptors in bacterial cell-free systems. Acta Naturae. 2012;4(15):58−64. doi: 10.32607/20758251-2012-4-4-58-64</mixed-citation><mixed-citation xml:lang="ru">Lyukmanova EN, Shenkarev ZO, Khabibullina NF, et al. N-terminal fusion tags for effective production of g-protein-coupled receptors in bacterial cell-free systems. Acta Naturae. 2012;4(4):58−64.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><mixed-citation>Saez NJ, Cristofori-Armstrong B, Anangi R, King GF. A Strategy for Production of Correctly Folded Disulfide-Rich Peptides in the Periplasm of E. coli. Methods Mol Biol. 2017;1586:155−180. doi: 10.1007/978-1-4939-6887-9_10</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Li J, Zhang H, Liu J, Xu K. Novel genes encoding six kinds of three-finger toxins in Ophiophagus hannah (king cobra) and function characterization of two recombinant long-chain neurotoxins. Biochem J. 2006;398(2):233−242. doi: 10.1042/BJ20060004</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Clement H, Flores V, De la Rosa G, Zamudio F, Alagon A, Corzo G. Heterologous expression, protein folding and antibody recognition of a neurotoxin from the Mexican coral snake Micrurus laticorallis. J Venom Anim Toxins Incl Trop Dis. 2016;22(1):25. doi: 10.1186/s40409-016-0080-9</mixed-citation></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Lyukmanova EN, Shulga AA, Arsenieva DA, et al. A Large-Scale Expression in Escherichia coli of Neurotoxin II from Naja oxiana Fused with Thioredoxin. Russ J Bioorg Chem. 2004;30(1):25−34. doi: 10.1023/B:RUBI.0000015770.38602.e3</mixed-citation><mixed-citation xml:lang="ru">Lyukmanova EN, Shulga AA, Arsenieva DA, et al. A Large-Scale Expression in Escherichia coli of Neurotoxin II from Naja oxiana Fused with Thioredoxin. Russian Journal of Bioorganic Chemistry. 2004;30(1):25−34. doi: 10.1023/B:RUBI.0000015770.38602.e3</mixed-citation></citation-alternatives></ref></ref-list></back></article>
